Why AMAG Pharmaceuticals Stock Is Skyrocketing Today

Shares of AMAG Pharmaceuticals (NASDAQ: AMAG) were skyrocketing 44.6% higher as of 11:10 a.m. EDT on Thursday. The huge jump began Thursday morning after Bloomberg reported that Covis Pharma, a drugmaker backed by Apollo Global Management (NYSE: APO), is in talks to acquire AMAG. Covis confirmed this report later in the day by announcing that it plans to buy AMAG for around $647 million.

Covis' offer reflects a 46% premium above AMAG's closing price on Wednesday. So why hasn't the biotech stock moved even higher today? Investors realize that there's always a chance that the deal won't close for some reason.

Image source: Getty Images.

Continue reading

Source Fool.com